These data suggest that TFPBC exhibited the best therapeutic efficacy with the highest expression of apoptosis marker cleaved caspase 3 and the lowest expression of tumor progressive markers P53 and Ki-67, and immune checkpoint protein PD-L1. Here, TP53 is linked to neoplasm.